Herishanu, Y, Shaulov, A, Fineman, R, Basic-Kinda, S, Aviv, A, Wasik-Szczepanek, E, Jaksic, O, Zdrenghea, M
, Greenbaum, U, Mandac, I, Simkovic, M, Morawska, M, Benjamini, O, Spacek, M, Nemets, A, Bairey, O, Visentin, A, Ruchlemer, R, Laurenti, L, Ciocan, OS, Doubek, M, Shvidel, L, Deli, N, Miras Calvo, F, De Meuter, A, Dimou, M, Mauro, FR, Coscia, M, Bumbea, H, Robert, S, Tadmor, T, Gutwein, O, Gentile, M, Scarfo, L, Tedeschi, A, Sportoletti, P, Gimeno Vazquez, E, Marquet Palomanes, J, Assouline, S, Papaioannou, M, Breaster, A, Levato, L, Gregor, M, Rigolin, GM, Loscertales, J, Medina Perez, A, Nijziel, MR, Popov, VM, Collado, R, Slavutsky, I, Levi, S, Polliack, A & Ghia, P 2019, '
Front-Line Treatment with Obinutuzumab +/- Chlorambucil for Chronic Lymphocytic Leukemia in Real-World Clinical Practice: Results of a Multinational, Multicenter Study By Eric and Icllsg',
Blood, vol. 134.
https://doi.org/10.1182/blood-2019-122309